期刊文献+

多孔球状淀粉接枝共聚物的应用 被引量:1

APPLICATION OF POROUS STARCH GRAFT COPOLYMER IN CONTROLLED RELEASS MEDICINE
下载PDF
导出
摘要 以反相悬浮法制备的多孔球状淀粉接枝共聚物为载体 ,采用直接压片法制得药物非诺落芬钙的缓释片剂。测定了缓释片剂中非诺落芬钙的体外溶出速率 ,非诺落芬钙在人工肠液中 3 h缓释片剂释放率为3 5%~ 51 % ,全部溶出时间大于 1 2 h,而淀粉与非诺落芬钙压制的淀粉药片中的非诺落芬钙 3 h已全部释放出来。缓释片剂中非诺落芬钙在人工胃液中 4 h释放 3 %~ 1 9% ,随着缓释片剂中多孔球状淀粉接枝共聚物用量增加 ,非诺落芬钙的体外溶出速率也增加。用 WT5,5”BZ] The tablets containing fenoprofen calcium(FC) were prepared by directly compressing the mixture of porous starch graft copolymers and drug powders. The effects of the mass ratio of the porous starch graft copolymers to fenoprofen calcium on the release rates of drugs in artificial intestinal and gastric fluids were examined. It was observed that approximately from 35% to 51% of FC release at pH 7.2 within 3 h, 100% of FC release at pH 7.2 over 12 h, about 3% to 19% release of FC was also observed during treated with 1.0 mol/L HCl (pH 1.2) for 4 h. FTIR spectroscopy were used for the confirmation of the graft copolymer and FC, the results indicated that inter molecular hydrogen bond was formed between the porous starch graft copolymers and FC. Release of FC from tablets in vitro indicated that the copolymer is suitable inclusion compound for fenoprofen calcium.
出处 《精细石油化工》 CAS CSCD 北大核心 2001年第1期44-46,共3页 Speciality Petrochemicals
关键词 多孔球状淀粉接枝共聚物 药物 非诺落芬钙 缓释片剂 应用 porous starch graft copolymer medicine fenoprofen calcium controlled releas applicatio$
  • 相关文献

参考文献2

二级参考文献3

共引文献31

同被引文献25

  • 1钱春梅.药物传递系统(DDS)Ⅳ腔道给药传递系统[J].西北药学杂志,1995,10(6):281-283. 被引量:5
  • 2郑文杰,何燕岭,黄宁兴.靶向给药系统材料与制剂[J].中国药学杂志,1996,31(11):664-667. 被引量:10
  • 3Carr BI,Zajko A,Bron K,et al.Study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma:interim analysis.Semin Oncol,1997,24(
  • 4Rongved P,Lindberg B,Klaveness J.Cross-linked,degradable starch microspheres as carriers of paramagnetic contrast agents for magnetic resonance imaging:synthesis,degradation,and relaxation properties.Carbohydr Res,1991,214(2):325-330.
  • 5Murata T,Akagi K,Imamura.M,et al.Studies on hyperthermia combined with arterial therapeutic blockade for treatment of tumors:(Part Ⅲ ) effectiveness of hyperthermia combined with arterial chemoembolization using degradable starch microspheres on advanced
  • 6Taguchi T,Tanikawa K,Sano K,et al.Multi-center cooperative phase Ⅱ study of combined infusion of PJ-203 (degradable starch microspheres) into hepatic artery in metastatic liver cancer.Gan To Kagaku Ryoho,1993,20(13):2015-25.
  • 7Gupta PK,Hung CT.Magnetically controlled targeted micro-carrier systems .Life Sci,1989,44(3):175-186.
  • 8Heritage PL,Loomes LM,Jianxiong J,et al.Novel polymer-grafted starch microparticles for mucosal delivery of vaccines.Immunology,1996,88( 1 ):162-168.
  • 9Yokoyama M,Okano T.Targeting of anti-cancer drugs with nanosized carrier system.Nippon Rinsho,1998,56(12):3227-3234.
  • 10Schutt W,Gruttner C,Teller J,et al.Biocompatible magnetic polymer carriers for in vivo radionuclide delivery.Artif Organs,1999,3(1):98-103

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部